Magazine Article | July 1, 2021

How A First-Time CEO Transformed Retrophin Into Travere Therapeutics

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL


That was the first thought Eric Dube, Ph.D., had when an executive recruiter pitched to him a CEO opportunity at Retrophin back in 2018. After all, Dube knew of the San Diego-based biopharma’s infamous past with its cofounder and one-time CEO, Martin Shkreli, so his initial reaction was to be dubious.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader